Product Description
Mabtas N 500 Infusion 50ml is primarily used to manage various types of blood cancers. It belongs to a class of medicines known as monoclonal antibodies.
This medicine is employed in the management of blood cancers, rheumatoid arthritis, and certain autoimmune disorders. In these conditions, it helps control inflammation and reduce symptoms, offering relief to the patients.
Before starting this medicine, it's vital to consult your doctor, who will guide you on the appropriate dosage and frequency. Ensure you inform your doctor about any pre-existing diseases or ongoing medications. If you experience any side effects while on this medicine, inform your doctor immediately. For the best results, continue the medicine for the duration prescribed by your doctor.
Advanced Treatment with RituximabMabtas N, branded internationally as Rituxan, utilizes the active ingredient Rituximab-a targeted monoclonal antibody. This therapy has revolutionized the management of some cancers and autoimmune conditions by precisely eliminating abnormal cells, minimizing harm to healthy tissues. Its efficacy in treating Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Rheumatoid Arthritis is clinically validated and endorsed by regulatory authorities.
Safety and Administration GuidelinesAdministered as an intravenous infusion by healthcare professionals, Mabtas N is for adult patients and provided as a single-use vial. Adhering to strict dosing protocols determined by a physician is essential for safety and effectiveness. Patients should never attempt administration outside a medical facility, and all unused medication must be discarded to avoid contamination.
Proper Storage and HandlingMabtas N requires storage in a refrigerator at 2C to 8C and must never be frozen. Each box contains a single vial, and the solution maintains stability for up to 18 months when properly stored. Mismanagement of storage can compromise efficacy, so always keep it at the recommended temperature until use.
FAQ's of Mabtas N:
Q: How is Mabtas N administered to patients?
A: Mabtas N is given through intravenous infusion by trained healthcare professionals in a clinical setting. The dosage and schedule are determined by your physician based on your medical condition.
Q: What conditions does Mabtas N treat?
A: Mabtas N, containing rituximab, is recommended for the treatment of Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Rheumatoid Arthritis in adults.
Q: When should Mabtas N be used during treatment?
A: The timing and frequency of Mabtas N infusions depend on your physician's assessment, disease type, and response to therapy. Always follow your specialist's schedule closely.
Q: Where should Mabtas N be stored before use?
A: This injection must be stored in a refrigerator at temperatures between 2C and 8C and should not be frozen. Keep it in its original packaging until ready for administration.
Q: What is the benefit of using Mabtas N in therapy?
A: Mabtas N specifically targets diseased cells in cancers and autoimmune illnesses, offering effective disease control and improved patient outcomes while reducing damage to healthy tissues.
Q: How should unused Mabtas N solution be handled?
A: Mabtas N is intended for single use only. Any unused solution after administration must be discarded as per medical guidelines to ensure patient safety.
Q: Is a prescription needed to obtain Mabtas N?
A: Yes, Mabtas N is a prescription medication and should only be supplied and administered under the supervision of a licensed healthcare professional.